Ipsen Launches Educational Initiative to Support Teens and Young Adults Moving From Pediatric to Adult Healthcare
IPSEN SA S/ADR (IPSEY)
NASDAQ:AMEX Investor Relations:
ipsen.com/investors
Company Research
Source: Business Wire
45 percent of 18- to 29-year-olds do not have a primary care physician.1 For patients with chronic conditions, the consequences can be significant.2Resources for parents, teens and young adults available at Healthcare-Shift.com CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen, a global biopharmaceutical company, today announced a new initiative aimed at increasing awareness and education around the transition from pediatric to adult healthcare, which typically occurs around ages 18 to 21 and for which many teens and families may be unprepared.3This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023481908/en/Healthcare-Shift.com offers parents, teens and young adults resources to help young adults make the shift from pediatric to adult healthcare, including a healthcare checklist, conversation guide and appointment guide, as well as video with experts that parents and teens can watch together.Through Healthcare-Shift.com, the compa
Show less
Read more
Impact Snapshot
Event Time:
IPSEY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPSEY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPSEY alerts
High impacting IPSEN SA S/ADR news events
Weekly update
A roundup of the hottest topics
IPSEY
News
- Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigueGlobeNewswire
- IPSEN (OTCMKTS:IPSEY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- EQT Life Sciences' ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billionPR Newswire
- Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidanceGlobeNewswire
- Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipelineGlobeNewswire